Cognitive impairment after cerebrovascular stroke: Relationship to vascular risk factors

Neuropsychiatric Disease and Treatment

Volumn 5, Issue 1, 2009, Pages 103-116

  Khedr, Eman M ^a   Hamed, Sherifa Ahmed ^a   El Shereef, Hala K ^a   Shawky, Ola A ^a   Mohamed, Khalid A ^a   Awad, Effat M ^a   Ahmed, Mohamed A ^a   Shehata, Ghaydaa A ^a   Eltahtawy, Mahmoud A ^a  

^a Assiut University Faculty of Medicine   (Egypt)

Author keywords

Homocysteine; Post stroke dementia; Vascular risk factors

Indexed keywords

HOMOCYSTEINE;

ADULT; AGE; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BRAIN INFARCTION SIZE; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DISEASE SEVERITY; EDUCATION; EVENT RELATED POTENTIAL; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; PROSPECTIVE STUDY; RISK FACTOR; SMOKING;

EID: 70449709095     PISSN: 11766328     EISSN: 11782021     Source Type: Journal    
DOI: None     Document Type: Article

References (84)

1. Barba R, Martinez ES, Rodriguez GE, Pondal M, Vivancos J, Del Ser T. Poststroke dementia: clinical features and risk factors. Stroke. 2000;31:1494-1501. (Pubitemid 30437493)
2. De Haan RJ, Limburg M, Van Der Meulen JH, Jacobs HM. Quality of life after stroke. Impact of stroke type and lesion location. Stroke. 1995;26:402-408.
3. Román GC. Vascular dementia revisited. Diagnosis, pathogenesis, treatment, and prevention. Med Clin North Am. 2002;86:477-499.
4. Pohjasvaara T, Erkinjuntti T, Yilkoski R, Hietanen M, Vataja R, Kaste M. Clinical determinants of poststroke dementia. Stroke. 1998;29:75-81.
5. Tatemichi TK, Paik M, Bagiella E, et al. Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study. Neurology. 1994;44:1885-1891. (Pubitemid 24319216)
6. Leys D, Hénon H, Mackowiak-Cordoliani MA, Pasquier F. Poststroke dementia. Lancet Neurol. 2005;4:752-1729
7. Tatemichi TK, Foulkes MA, Mohr JP, et al. Dementia in stroke survivors in the Stroke Data Bank cohort: prevalence, incidence, risk factors and computed tomographic findings. Stroke. 1990;21:858-866.
8. Hénon H, Pasquier F, Leys D. Poststroke dementia. Cerebrovasc Dis. 2006;22:61-70.
9. Snaphaan L, de Leeuw FE. Poststroke memory function in nondemented patients: a systematic review on frequency and neuroimaging correlates. Stroke. 2007;38:198-203. (Pubitemid 46043196)
10. Tham W, Auchus AP, Thong M, et al. Progression of cognitive impairment after stroke: one year results from a longitudinal study of Singaporean stroke patients. J Neurol Sci. 2002;203-204:49-52. (Pubitemid 35287374)
11. Desmond DW, Moroney JT, Sano M, Stern Y. Recovery of cognitive function after stroke. Stroke. 1996;27:1798-1803.
12. Kokmen E, Whisnant JP, O'Fallon WM, Chu CP, Beard CM. Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960-1984). Neurology. 1996;19:154-159.
13. Serrano S, Domingo J, Rodríguez-Garcia E, Castro MD, del Ser T. Frequency of cognitive impairment without dementia in patients with stroke: a two-year follow-up study. Stroke. 2007;38:105-110. (Pubitemid 46035614)
14. Bostom AG, Rosenberg IH, Silbershatz H, et al. Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women. Arch Intern Med. 1999;159:1077-1080. (Pubitemid 29230859)
15. Hogervorst E, Ribiero HM, Molyneux A, Budge M, Smith D. Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease. Arch Neurol. 2002;59:787-793. (Pubitemid 34517761)
16. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med. 2002;346:476-483. (Pubitemid 34441738)
17. Tay SY, Ampil ER, Chen CPLH, Auchus AP. The relationship between homocysteine, cognition and stroke subtypes in acute stroke. J Neurol Sci. 2006;250:58-61. (Pubitemid 44687437)
18. Ho GY, Eikelboom JW, Hankey GJ, et al. Methylenetetrahydrofolate reductase polymorphisms and homocysteine-lowering effect of vitamin therapy in Singaporean stroke patients. Stroke. 2006;37:456-460.
19. Jorm AF. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): A review. Int Psychogeriatr. 2004;6:1-19.
20. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial: TOAST: Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35-41.
21. Widder B, Paulat K, Hackpacker J, et al. Morphological characterization of carotid artery stensis by ultrasound duplex scanning. Ultras Med Boil. 1990;16:349-354. (Pubitemid 20241978)
22. Folstein MF, Folstein SE, McHugh PH. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
23. Teng EL, Hasegawa K, Homma A, et al. The cognitive abilities screening instrument (CASI): A practical test for cross-cultural epidemiological studies of dementia. Int Psychogeriatr. 1994;6:45-58.
24. Wechsler D. Wechsler Memory Scales-Revised. New York: Psychological Corporation; 1987.
25. Polich J. P300 clinical utility and control of variability. J Clin Neurophysiol. 1998;15:14-33. (Pubitemid 29090720)
26. Lindenstrom E, Boysen G, Christiansen LW, Hansen BR, Nielsen PW. Reliability of Scandinavian Neurological Stroke Scale. Cerebrovasc Dis. 1991;23:646-652.
27. Mahoney FL, Barthel DW. Functional evaluation: The Barthel index. Md State Med J. 1965;114:61.
28. Michele VD. Bolino F. Post stroke depression. Br J Psychiatr. 2000;176:94-95.
29. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association; 1994.
30. Jonkman EJ, De Weerd AW, Verijens NL. Quality of life after first ischemic stroke. Long term development and correlation with changes in neurological deficity, mood and cognitive impairment. Acta Neurol Scand. 1998;98:169-175.
31. Pohjasvaara T, Mantyla R, Ylikoski R, Kaste M, Erkinjuntti T. Comparison of different clinical criteria (DSM-III, ADDTC, ICD-10, NINDS-AIREN, DSM-IV) for the diagnosis of vascular dementia. National Institute of Neurological Disorders and Stroke-Association Internationale pour la Rechherche et I'Enseignement en Neurosciences. Stroke. 2000;31:2952-2957.
32. Madureira S, Guerreiro M, Ferro JM. Dementia and cognitive impairment three months after stroke. Eur J Neurol. 2001;8:621-627. (Pubitemid 35015229)
33. Tatemichi TK, Desmond DW, Mayeux R, et al. Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology. 1992;42:1185-1193.
34. Frodl-Bauch, T, Bottlender, R, Hegerl, U. Neurochemical substrates and neuroanatomical generators of the event-related P300. Neuropsychobiology. 1999;40:86-94. (Pubitemid 29410826)
35. Stoquart-ElSankari S, Balédent O, Gondry-Jouet C, Makki M, Godefroy O, Meyer ME. Aging effects on cerebral blood and cerebrospinal fluid flows. J Cereb Blood Flow Metab. 2007;27:1563-1572. (Pubitemid 47301448)
36. Gorelick PB. Status of risk factors for dementia associated with stroke. Stroke. 1997;28:459-463. (Pubitemid 27097022)
37. Farrage AF, Khedr EM, Abdel-Aleem H, Rageh TA. Effect of surgical menopause on cognitive functions. Dement Geriatr Cogn Disord. 2002;13:193-198. (Pubitemid 34224939)
38. McDowell I, Xi G, Lindsay J, Tierney M. Mapping the connections between education and dementia. J Clin Exp Neuropsychol. 2007;29:127-141.
39. Ngandu T, von Strauss E, Helkala EL, et al. Education and dementia: what lies behind the association? Neurology. 2007;69:1442-1450. (Pubitemid 47511466)
40. Tomlinson BE, Blessed G, Roth M. Observations on the brains of demented old people. J Neurol Sci. 1970;11:205-242.
41. Yao H, Sadoshima S, Ibayashi S. Leukoaraiosis and dementia in hypertensive patients. Stroke. 1992;23:1673-1677.
42. Vinters HV, Ellis WG, Zarow C, et al. Neuropathologic substrates of ischemic vascular dementia. J Neuropathol Exp Neurol. 2000;59:931-945. (Pubitemid 30823308)
43. Saver JL, Biller J. Superficial middle cerebral artery. In: Bogousslavsky J, Caplan L, editors. Stroke syndromes. Cambridge: Cambridge University Press; 1995. p. S247-S258.
44. Ballard C, Rowan E, Stephens S, Kalaria R, Kenny RA. Prospective follow-up study between 3 and 15 months after stroke improvements and decline in cognitive function among dementia-free stroke survivors >75 years of age. Stroke. 2003;34:2440-2444. (Pubitemid 37221958)
45. Censori B, Manara O, Agostinis C, et al. Dementia after first stroke. Stroke. 1996;27:1205-1210.
46. Ott A, Andersen K, Dewey ME, et al. Effect of smoking on global cognitive function in nondemented elderly. Neurology. 2004;62:920-924. (Pubitemid 38435779)
47. Sabia S, Marmot M, Dufouil C, Singh-Manoux A. Smoking history and cognitive function in middle age from the Whitehall II study. Arch Intern Med. 2008;168:1165-1173. (Pubitemid 351831399)
48. Ikeda A, Yamagishi K, Tanigawa T, et al. Cigarette smoking and risk of disabling dementia in a Japanese rural community: a nested case-control study. Cerebrovasc Dis. 2008;25:324-331. (Pubitemid 351555855)
49. Almeida OP, Garrido GJ, Lautenschlager NT, Hulse GK, Jamrozik K, Flicker L. Smoking is associated with reduced cortical regional gray matter density in brain regions associated with incipient Alzheimer disease. Am J Geriatr Psychiatry. 2008;16:92-98.
50. Anstey KJ, von Sanden C, Salim A, O'Kearney R. Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am J Epidemiol. 2007;166:367-378. (Pubitemid 47216800)
51. Siennicki-Lantz A, Reinprecht F, Wollmer P, Elmståhl S. Smoking-related changes in cerebral perfusion in a population of elderly men. Neuroepidemiology. 2008;30:84-92.
52. In't Veld BA, Ruitenberg A, Hofman A, Stricker BA, Breteler MMB. Antihypertensive drugs and incidence of dementia: The Rotterdam Study. Neurobiol Aging. 2001;22:407-412.
53. Harrington F, Saxby BK, McKeith IG, Wesnes K, Ford GA. Cognitive performance in hypertensive and normotensive older subjects. Hypertension. 2000;36:1079-1082.
54. Birkenhäger WH, Forette F, Seux ML, Wang JG, Staessen JA. Blood pressure, cognitive functions, and prevention of dementias in older patients with hypertension. Arch Intern Med. 2001;161:152-156. (Pubitemid 32102382)
55. Ott A, Breteler MM, de Bruyne MC, van Harskamp F, Grobbee DE, Hofman A. Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke. 1997;28:316-321. (Pubitemid 27096997)
56. Hemmingsson T, v Essen J, Melin B, Allebeck P, Lundberg I. The association between cognitive ability measured at ages 18-20 and coronary heart disease in middle age among men: a prospective study using the Swedish 1969 conscription cohort. Soc Sci Med. 2007;65:1410-1419.
57. Komulainen P, Kivipelto M, Lakka TA, Hassinen M, Helkala EL, Patja K, Nissinen A, Rauramaa R. Carotid intima-media thickness and cognitive function in elderly women: a population-based study. Neuroepidemiology. 2007;28:207-213. (Pubitemid 47573715)
58. Talelli P, Ellul J, Terzis G, Lekka NP, Gioldasis G, Chrysanthopoulou A, Papapetropoulos T. Common carotid artery intima media thickness and post-stroke cognitive impairment. J Neurol Sci. 2004;223:129-134. (Pubitemid 39164354)
59. Lee YH, Yeh SJ. Correlation of common carotid artery intima media thickness, intracranial arterial stenosis and post-stroke cognitive impairment. Acta Neurol Taiwan. 2007;16:207-213.
60. Rao R, Jackson S, Howard R. Neuropsychological impairment in stroke, carotid stenosis, and peripheral vascular disease, A comparison with healthy community residents. Stroke. 1999;30:2167-2173. (Pubitemid 29473265)
61. Kimura M, Robinson RG, Kosier JT. Treatment of cognitive impairment after poststroke depression, a double-blind treatment trial. Stroke. 2000;31:1482-1486. (Pubitemid 30437491)
62. Murata Y, Kimura M, Robinson RG. Does cognitive impairment cause poststroke depression? Am J Geriatr Psychiatry. 2000;8:310-317. (Pubitemid 30782253)
63. Tanne D, Haim M, Goldbourt U, et al. Prospective study of serum homocysteine and risk of ischemic stroke among patients with preexisting coronary heart disease. Stroke. 2003;34:632-636. (Pubitemid 36307383)
64. van Raamt AF, Kalmijn S, Mali WP, van Zandvoort MJ, van der Graaf Y; SMART Study Group. Homocysteine level and cognitive function in patients with arterial disease: the second manifestations of ARTerial Disease Study. J Am Geriatr Soc. 2006;54:575-579.
65. Stein JH, McBride PE. Hyperhomocysteinemia and atherosclerotic vascular disease: pathophysiology, screening and treatment, Arch Intern Med. 1998;158:1301-1306.
66. Boysen G, Brander T, Christensen H, Gideon R, Truelsen T. Homocysteine and risk of recurrent stroke. Stroke. 2003;34:1258-1261.
67. Henon H, Godefroy O, Luca Ch, Pruvo JP, Leys D. Risk factors and leukoaraiosis in stroke patients. Acta Neurol Scand. 1996;94:137-144. (Pubitemid 26308801)
68. Stamler JS, Slivka A. Biological chemistry of thiols in the vasculature and in vascular-related disease. Nutr Rev. 1996;54:1-30. (Pubitemid 26110649)
69. Budge MM, de Jager C, Hogervorst E, Smith AD. Total plasma homocysteine, age, systolic blood pressure, and cognitive performance in older people. J Am Geriatr Soc. 2002;50:2014-2018. (Pubitemid 35462448)
70. Prins ND, Den Heijer T, Hofman A, et al. Homocysteine and cognitive function in the elderly, The Rotterdam Scan Study. Neurology. 2002;59:1375-1380. (Pubitemid 35285990)
71. Dufouil C, Alpérovitch A, Ducros V, Tzourio C. Homocysteine, white matter hyperintensities, and cognition in healthy elderly people. Ann Neurol. 2003;53:214-221. (Pubitemid 36164003)
72. Folsom AR, Nieto FI, McGovern PG, et al. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms and B vitamins: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 1998;98:204-210.
73. Marszałł M, Czarnowski W. Smoking influence on the level of homocysteine and 5-methyltetrahydrofolic acid in active and non smokers. Przegl Lek. 2007;64:685-688.
74. Eikelboom JW, Hankey GJ, Anand SS, Lofthouse E, Staples N, Baker RI. Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke. Stroke. 2000;31:1069-1075. (Pubitemid 30253527)
75. Samson RH, Yungst Z, Showalter DP. Homocysteine, a risk factor for carotid atherosclerosis, is not a risk factor for early recurrent carotid stenosis following carotid endarterectomy. Vasc Endovascular Surg. 2004;38:345-348. (Pubitemid 39079939)
76. Lehmann M, Gottfries CG, Regland B. Identification of cognitive impairment in the elderly: homocysteine is an early marker. Dement Geriatr Cogn Disord. 1999;10:12-20. (Pubitemid 28567038)
77. Sachdev PS, Valenzuela MJ, Brodaty H, et al. Homocysteine as a risk factor for cognitive impairment in stroke patients. Dement Geriatr Cogn Disord. 2003;15:155-162. (Pubitemid 36206645)
78. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM. Folate, vitamin B12, and serum homocysteine levels in confirmed Alzheimer's disease. Arch Neurol. 1998;55:1449-1455. (Pubitemid 28525506)
79. Den Heijer T, Vermeer SE, Clarke R, et al. Homocysteine and brain atrophy on MRI of non-demented elderly. Brain. 2003;126:170-175. (Pubitemid 36068567)
80. Nilsson K, Gustafson L, Hultberg B. Elevated plasma homocysteine concentration in elderly patients with mental illness is mainly related to the presence of vascular disease and not the diagnosis. Dement Geriatr Cogn Disord. 2007;24:162-168. (Pubitemid 47312665)
81. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med. 1994;330:613-622. (Pubitemid 24984686)
82. White AR, Huang X, Jobling MF, et al. Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary neuronal cultures: Possible risk factors in the Alzheimer's-type neurodegenerative pathways. J Neurochem. 2001;76:1507-1520. (Pubitemid 32198255)
83. Aisen PS, Egelko S, Andrews H, et al. A pilot study of vitamins to lower plasma homocysteine levels in Alzheimer disease. Am J Geriatr Psychiatry. 2003;11:246-249. (Pubitemid 36254199)
84. Schroecksnadel K, Frick B, Fuchs D. Immune Activation to Underlie Moderate Hyperhomocysteinemia in Stroke and Dementia. Stroke. 2003;34:833-844.